Literature DB >> 16223590

Hematologically important mutations: ankyrin variants in hereditary spherocytosis.

Patrick G Gallagher1.   

Abstract

The primary defect in the hereditary spherocytosis (HS) syndromes is a qualitative or quantitative alteration in one or more erythrocyte membrane proteins. Mutation of the erythrocyte membrane protein ankyrin are the most common cause of typical, dominant HS. Ankyrin mutations also cause nondominant spherocytosis due to ankyrin gene promoter or de novo mutations. In most cases, HS-related ankyrin mutations are private. A summary of reported HS-associated ankyrin gene mutations is provided in this report.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223590     DOI: 10.1016/j.bcmd.2005.08.008

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  30 in total

1.  A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis.

Authors:  Michael R Hughes; Nicole Anderson; Steven Maltby; Justin Wong; Zorana Berberovic; Connie S Birkenmeier; D James Haddon; Kamal Garcha; Ann Flenniken; Lucy R Osborne; S Lee Adamson; Janet Rossant; Luanne L Peters; Mark D Minden; Robert F Paulson; Chen Wang; Dwayne L Barber; Kelly M McNagny; William L Stanford
Journal:  Exp Hematol       Date:  2010-12-28       Impact factor: 3.084

2.  Structurally similar but functionally diverse ZU5 domains in human erythrocyte ankyrin.

Authors:  Mai Yasunaga; Jonathan J Ipsaro; Alfonso Mondragón
Journal:  J Mol Biol       Date:  2012-01-30       Impact factor: 5.469

3.  Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis.

Authors:  Patrick G Gallagher; Laurie A Steiner; Robert I Liem; Ashley N Owen; Amanda P Cline; Nancy E Seidel; Lisa J Garrett; David M Bodine
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

4.  Functional analysis of a novel cis-acting regulatory region within the human ankyrin gene (ANK-1) promoter.

Authors:  Karina Laflamme; Ashley N Owen; Emily E Devlin; Mary Q Yang; Clara Wong; Laurie A Steiner; Lisa J Garrett; Laura Elnitski; Patrick G Gallagher; David M Bodine
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

5.  Analysis of novel sph (spherocytosis) alleles in mice reveals allele-specific loss of band 3 and adducin in alpha-spectrin-deficient red cells.

Authors:  Raymond F Robledo; Amy J Lambert; Connie S Birkenmeier; Marius V Cirlan; Andreea Flavia M Cirlan; Dean R Campagna; Samuel E Lux; Luanne L Peters
Journal:  Blood       Date:  2010-01-07       Impact factor: 22.113

Review 6.  Host genetics in malaria: lessons from mouse studies.

Authors:  Hong Ming Huang; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Mamm Genome       Date:  2018-03-28       Impact factor: 2.957

7.  Structure of the ZU5-ZU5-UPA-DD tandem of ankyrin-B reveals interaction surfaces necessary for ankyrin function.

Authors:  Chao Wang; Cong Yu; Fei Ye; Zhiyi Wei; Mingjie Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

8.  Micrometric segregation of fluorescent membrane lipids: relevance for endogenous lipids and biogenesis in erythrocytes.

Authors:  Ludovic D'Auria; Marisa Fenaux; Paulina Aleksandrowicz; Patrick Van Der Smissen; Christophe Chantrain; Christiane Vermylen; Miikka Vikkula; Pierre J Courtoy; Donatienne Tyteca
Journal:  J Lipid Res       Date:  2013-01-14       Impact factor: 5.922

9.  Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer's Disease in Han Chinese.

Authors:  Song Chi; Jing-Hui Song; Meng-Shan Tan; Wei Zhang; Zi-Xuan Wang; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-11-26       Impact factor: 5.590

10.  A tissue-specific chromatin loop activates the erythroid ankyrin-1 promoter.

Authors:  Ashley O Yocum; Laurie A Steiner; Nancy E Seidel; Amanda P Cline; Emily D Rout; Jolinta Y Lin; Clara Wong; Lisa J Garrett; Patrick G Gallagher; David M Bodine
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.